The promise of new treatments that use the body’s own immune cells to fight cancer has sent soaring the value of a handful of biotech startups, and analysts say Big Pharma may be waiting in the wings with buyout offers as the science continues to progress.

…read more

Source: CAR-T’s explosion puts Juno and Kite under the M&A spotlight


0 No comments